Quantcast
Last updated on April 19, 2014 at 7:46 EDT

Latest NxStage Medical Inc. Stories

2012-08-29 02:26:06

LAWRENCE, Mass., Aug. 29, 2012 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that the American Association of Kidney Patients (AAKP) has honored NxStage System One(TM) patient Brian Hess with the Samuel J. Orenstein Award. The award is presented each year to the AAKP member who consistently provides extraordinary service in helping the organization achieve its goals to educate and improve the health and...

2012-08-10 02:23:05

LAWRENCE, Mass., Aug. 10, 2012 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Jeffrey H. Burbank, Chief Executive Officer, will present at the Canaccord Genuity 32(nd) Annual Growth Conference on Tuesday, August 14th, at 4:30 p.m. ET. A webcast of the event will be made available at http://ir.nxstage.com/ at the time of the presentation. (Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO )...

2012-05-24 10:24:07

LAWRENCE, Mass., May 24, 2012 /PRNewswire/ -- NxStage ® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced the latest interim findings from its FREEDOM (Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements) Study, which found daily home hemodialysis treatments with the NxStage System One(TM) are associated with long-term improvements in various physical and mental quality of life measures. These interim FREEDOM...

2012-05-14 02:27:35

LAWRENCE, Mass., May 14, 2012 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that former NxStage® System One(TM) patient Nikolas Gieske of Mequon, Wisconsin, received a kidney transplant following four successful years of more frequent home hemodialysis with the System One. (Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO ) The freedom to do his dialysis treatments on his own schedule...

2012-05-11 02:23:49

LAWRENCE, Mass., May 11, 2012 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq:NXTM), a leading manufacturer of innovative dialysis products, today commented on findings of the Chronic Disease Research Group (CDRG) study showing that patients receiving daily, or more frequent, home hemodialysis with the NxStage System One(TM) are more likely to receive a kidney transplant when compared with conventional thrice-weekly dialysis, particularly in patients not on the transplant waitlist at...

2012-05-08 02:27:47

LAWRENCE, Mass., May 8, 2012 /PRNewswire/ -- Highlights: Total Revenue Increases 13% to $57.0 million Home Revenue Increases 13% to $29.6 million Company Converts Outstanding Debt to Equity with Strategic Partner, Asahi Kasei Medical Co., Ltd. and Announces System One Collaboration in Japan NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today reported financial results for the first quarter ended March 31, 2012, with total revenue...

2012-04-13 02:21:46

LAWRENCE, Mass., April 13, 2012 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced plans to release its financial results for the first quarter ended March 31, 2012 on Tuesday, May 8, 2012 before the opening of the financial markets. (Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO) NxStage will also host a conference call at 9:00 a.m. Eastern Time on Tuesday, May 8, 2012 to discuss its first quarter...

2012-02-29 06:22:00

LAWRENCE, Mass., Feb. 29, 2012 /PRNewswire/ -- Highlights: Full-Year Revenue Increases to $217.3 Million, 21% Annual Growth Full-Year Home Revenue Increases to $108.5 Million, 27% Annual Growth Full- Year Gross Margin Improves to 36%, up from 32% for 2010 Q4'11 Revenue Increases to a Record $57.0 Million, up 15% from Q4'10 Company Applauds Favorable Coverage Decision Supporting More Frequent Home Hemodialysis by UnitedHealthcare NxStage® Medical, Inc. (Nasdaq: NXTM), a leading...

2012-02-24 07:26:00

LAWRENCE, Mass. and SAN ANTONIO, Feb. 24, 2012 /PRNewswire/ -- ADC 2012 Booth B -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that it is participating in several industry-focused educational presentations on more frequent home hemodialysis with the NxStage System One(TM) at the Annual Dialysis Conference (ADC) 2012. NxStage will also host a special reception event, featuring celebrity kidney transplant patient and former...

2012-01-20 10:59:00

LAWRENCE, Mass., Jan. 20, 2012 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced plans to release its financial results for the fourth quarter and full year ended December 31, 2011 on Wednesday, February 29, 2012 before the opening of the financial markets. (Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO ) NxStage will also host a conference call at 9:00 a.m. Eastern Time on Wednesday, February 29,...